What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
Gail V. Matthews spends much of his time researching Immunology, Hepatitis C, Hepatitis C virus, Internal medicine and Virology.
His research integrates issues of Liver disease and Incidence in his study of Immunology.
The various areas that Gail V. Matthews examines in his Hepatitis C study include Transmission and Men who have sex with men, Acquired immunodeficiency syndrome.
Gail V. Matthews is studying Ribavirin, which is a component of Hepatitis C virus.
His Ribavirin research includes elements of Seroconversion and Hepacivirus.
The various areas that he examines in his Internal medicine study include Sida and Zidovudine.
His most cited work include:
- Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. (319 citations)
- Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. (262 citations)
- Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): A non-randomised, open-label trial (232 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Hepatitis C, Hepatitis C virus, Immunology and Virology.
Gail V. Matthews interconnects Gastroenterology and Sofosbuvir in the investigation of issues within Internal medicine.
His Hepatitis C study combines topics in areas such as Men who have sex with men, Incidence, Intensive care medicine, Hepacivirus and Ribavirin.
In his study, which falls under the umbrella issue of Ribavirin, Pharmacotherapy is strongly linked to Alpha interferon.
His Hepatitis C virus research incorporates themes from Clinical trial, Cirrhosis, Antiviral therapy, Transmission and Drug.
His Liver disease research extends to the thematically linked field of Immunology.
He most often published in these fields:
- Internal medicine (66.29%)
- Hepatitis C (59.09%)
- Hepatitis C virus (47.35%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (66.29%)
- Hepatitis C (59.09%)
- Hepatitis C virus (47.35%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Hepatitis C, Hepatitis C virus, Incidence and Prospective cohort study.
Gail V. Matthews has included themes like Drug and Severe acute respiratory syndrome coronavirus 2 in his Internal medicine study.
Gail V. Matthews combines subjects such as Real world evidence, Ribavirin, Sofosbuvir, Virological response and Medical prescription with his study of Hepatitis C.
Hepatitis C virus is the subject of his research, which falls under Virology.
His work on Outbreak as part of general Virology study is frequently linked to Sequence analysis, therefore connecting diverse disciplines of science.
His work in Prospective cohort study tackles topics such as Viral load which are related to areas like Elbasvir and Grazoprevir.
Between 2018 and 2021, his most popular works were:
- A global scientific strategy to cure hepatitis B (119 citations)
- Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy (18 citations)
- Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy (18 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
His primary areas of study are Hepatitis C, Internal medicine, Hepatitis C virus, Incidence and Paritaprevir.
His biological study spans a wide range of topics, including Pibrentasvir, Adverse effect, Standard treatment, Glecaprevir and Clinical endpoint.
His Internal medicine research integrates issues from Public health interventions and 2019-20 coronavirus outbreak.
His work carried out in the field of Hepatitis C virus brings together such families of science as Men who have sex with men, Clinical trial, Prospective cohort study and Treatment as prevention.
His Incidence research is multidisciplinary, incorporating elements of Behavioural intervention and Cirrhosis.
His Paritaprevir research is multidisciplinary, incorporating perspectives in Ombitasvir, Dasabuvir, Sofosbuvir and Ritonavir.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
